Daxor Reports 26.5% Rise In Diagnostic Sales Revenue For 6 Months Ending June 30, 2021
Daxor Corporation (NYSE:DXR), the global leader in blood volume measurement technology, announces today it filed Form N-CSR disclosing its schedule of portfolio holdings for the six months ended June 30, 2021.
The
